IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q2 2023 Holdings

Filed 2023-07-24 | 31 holdings | $111.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr SER TR(BIL)BLOOMBERG 1-3 MO78468R663$18.4M200,00016.5%
Ishares TR(SGOV)0-3 MNTH TREASRY46436E718$18.1M180,00016.3%
Cyteir Therapeutics IncCOM23284P103$8.5M3,250,0007.6%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$8.4M2,236,2397.5%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$8.2M5,157,1797.4%
Pardes Biosciences IncCOM69945Q105$6.9M3,791,6336.2%
Talaris Therapeutics IncCOM87410C104$6.1M2,000,0005.5%
Athira Pharma IncCOM04746L104$5.5M1,864,9074.9%
Eliem Therapeutics Inc(CLYM)COM28658R106$4.4M1,583,1704.0%
Abercrombie & Fitch Co(ANF)CL A002896207$4.4M117,5004.0%
Astrotech Corp(ASTC)COM046484309$3.1M220,4102.8%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$3.0M850,0002.7%
Quince Therapeutics Inc(QNCX)COM22053A107$2.1M1,411,8391.9%
Passage BIO IncCOM702712100$1.9M2,058,7671.7%
Forte Biosciences Inc(TOCAEUR)COM34962G109$1.8M1,735,0751.6%
Enliven Therapeutics Inc(ELVN)COM29337E102$1.5M74,2321.4%
Arca Biopharma Inc(ABIOEUR)COM00211Y506$1.4M706,9301.3%
Tillys Inc(TLYS)CL A886885102$1.3M190,5181.2%
Lisata Therapeutics Inc(LSTA)COM128058302$902.2K243,8390.8%
Verrica Pharmaceuticals IncCOM92511W108$865.5K150,0000.8%
Surrozen IncCOM86889P109$802.5K1,459,0840.7%
Milestone Pharmaceuticals in(MIST)COM59935V107$776.6K272,5000.7%
Retractable Technologies Inc(RVP)COM76129W105$768.9K668,5750.7%
Nextcure IncCOM65343E108$551.6K306,4650.5%
Graphite BIO Inc(GRPH)COM38870X104$396.0K152,2910.4%
Calcimedica Inc(CALC)COM NEW38942Q202$356.0K88,7810.3%
Avrobio IncCOM05455M100$243.5K256,2770.2%
MEI Pharma Inc(LITS)COM55279B301$151.1K22,9660.1%
Invivyd Inc(IVVD)COM00534A102$141.4K134,6960.1%
Rain Oncology IncCOM75082Q105$87.5K72,9260.1%
Neoleukin Therapeutics IncCOM64049K104$19.7K23,7490.0%